ELAB - PMGC Holdings Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

ELAB

PMGC HOLDINGS INC.

NASDAQ

$6.66

▲ UP 9.18% (0.56)

KEY STATISTICS

Market Cap$3.03 M

52w High$2671.20

52w Low$5.40

Dividend Yield—

Frequency—

P/E-0.18

Volume204.02K

Shares Out.454.38K

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Graydon Bensler

COMPENSATION 2026

Salary$262,000

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$0

Total$697,800

ABOUT

SECTOR

Healthcare

WENT PUBLIC

November 21, 2023

METHOD OF GOING PUBLIC

SPAC

FULL TIME EMPLOYEES

SPLIT RECORD

DATE	TYPE	RATIO
2026-08-21	Reverse	1:10
2026-03-10	Reverse	1:6
2026-01-06	Reverse	1:4
2025-09-02	Reverse	2:7
2025-03-10	Reverse	1:7
2024-11-27	Reverse	1:200

PRICE

$6.66 ▲ UP 9.18% (+$0.56)

OVERLAYS

About PMGC Holdings Inc.

https://pmgcholdings.com ↗

PMGC Holdings Inc., a Newport Beach-based biopharmaceutical firm formerly Elevai Labs, develops innovative aesthetic and therapeutic products, including EL-22—a probiotic for obesity-related muscle preservation—while also engaging in research and ...

INDUSTRY

Biotechnology

A PRODUCT PMGC HOLDINGS INC. IS KNOWN FOR

EL-22

EL-22 is a pioneering engineered probiotic by PMGC Holdings aimed at preserving muscle mass during weight loss treatments like GLP-1 receptor agonists.